MEDI:GATE NEWS Hanmi Pharmaceutical’s main ingredient of cold mask confirmed the effect of blocking COVID-19
Shinpoong Pharmaceutical’s’Piramax’ approved for Phase 2/3 clinical trial in the Philippines for COVID-19 treatment
Celltrion applies for conditional approval for COVID-19 antibody treatment and initiates global approval